Scott RL - Search Results

1

Long-term outcome of cardiac allograft vasculopathy treated by transmyocardial laser revascularization: early rewards, late losses.

Mehra MR, Uber PA, Prasad AK, Park MH, Scott RL, McFadden PM, Van Meter CH. Mehra MR, et al. Among authors: scott rl. J Heart Lung Transplant. 2000 Aug;19(8):801-4. doi: 10.1016/s1053-2498(00)00139-x. J Heart Lung Transplant. 2000. PMID: 10967275

2

Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression.

Mehra MR, Uber PA, Scott RL, Park MH. Mehra MR, et al. Among authors: scott rl. Transplantation. 2002 Dec 15;74(11):1568-73. doi: 10.1097/00007890-200212150-00014. Transplantation. 2002. PMID: 12490790 Clinical Trial.

3

Is all intimal proliferation created equal in cardiac allograft vasculopathy? The quantity-quality paradox.

Mehra MR, Ventura HO, Uber PA, Scott RL, Park MH. Mehra MR, et al. Among authors: scott rl. J Heart Lung Transplant. 2003 Feb;22(2):118-23. doi: 10.1016/s1053-2498(02)00492-8. J Heart Lung Transplant. 2003. PMID: 12581758

4

The impact of mode of donor brain death on cardiac allograft vasculopathy: an intravascular ultrasound study.

Mehra MR, Uber PA, Ventura HO, Scott RL, Park MH. Mehra MR, et al. Among authors: scott rl. J Am Coll Cardiol. 2004 Mar 3;43(5):806-10. doi: 10.1016/j.jacc.2003.08.059. J Am Coll Cardiol. 2004. PMID: 14998621 Free article.

5

Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation.

Mehra MR, Uber PA, Potluri S, Ventura HO, Scott RL, Park MH. Mehra MR, et al. Among authors: scott rl. Am J Cardiol. 2004 Aug 15;94(4):454-8. doi: 10.1016/j.amjcard.2004.04.060. Am J Cardiol. 2004. PMID: 15325928

6

Relationship among epicardial coronary disease, tissue myocardial perfusion, and survival in heart transplantation.

Potluri SP, Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO. Potluri SP, et al. Among authors: scott rl. J Heart Lung Transplant. 2005 Aug;24(8):1019-25. doi: 10.1016/j.healun.2004.07.017. J Heart Lung Transplant. 2005. PMID: 16102436

7

Cardiac allograft valvulopathy: a case of donor-anorexigen-induced valvular disease.

Prasad A, Mehra M, Park M, Scott R, Uber PA, McFadden PM. Prasad A, et al. Ann Thorac Surg. 1999 Nov;68(5):1840-1. doi: 10.1016/s0003-4975(99)00751-1. Ann Thorac Surg. 1999. PMID: 10585071

8

Does hyperuricemia predict adverse clinical outcome while awaiting heart transplantation?

Uber PA, Mehra MR, Park MH, Ventura H, Scott RL. Uber PA, et al. Among authors: scott rl. J Heart Lung Transplant. 2001 Feb;20(2):164-165. doi: 10.1016/s1053-2498(00)00300-4. J Heart Lung Transplant. 2001. PMID: 11250249 No abstract available.

9

Does HDL-cholesterol level predict clinical outcome in advanced heart failure?

Mehra MR, Uber PA, Park MH, Scott RL, Milani RV. Mehra MR, et al. Among authors: scott rl. J Heart Lung Transplant. 2001 Feb;20(2):165. doi: 10.1016/s1053-2498(00)00301-6. J Heart Lung Transplant. 2001. PMID: 11250251 No abstract available.

10

The differential metabolic impact of tacrolimus and cyclosporine immunosuppression in black heart transplant recipients: hyperlipidemia, hypertension and hyperglycemia.

Uber PA, Mehra MR, Vivekananthan N, Scott RL, Park MH. Uber PA, et al. Among authors: scott rl. J Heart Lung Transplant. 2001 Feb;20(2):192. doi: 10.1016/s1053-2498(00)00401-0. J Heart Lung Transplant. 2001. PMID: 11250329 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters